Premium
Palliative care patients have worsening symptoms of delirium with risperidone, haloperidol
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30222
Subject(s) - risperidone , delirium , haloperidol , palliative care , medicine , psychiatry , antipsychotic , lorazepam , placebo , psychology , alternative medicine , schizophrenia (object oriented programming) , nursing , pathology , dopamine
Antipsychotic drugs often are prescribed to relieve symptoms of delirium in patients receiving palliative care, but a randomized trial has found that patients receiving an antipsychotic over a 72‐hour period actually saw a worsening of delirium symptoms relative to placebo.